+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aminoglycosides Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 87 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 5394870
Description Jump to:
Aminoglycosides, including gentamicin, amikacin, and tobramycin, are broad-spectrum antibiotics critical for treating multidrug-resistant (MDR) bacterial infections, particularly Gram-negative pathogens like Escherichia coli and Pseudomonas aeruginosa. The market is driven by the global rise of antimicrobial resistance, causing 1.27 million direct deaths annually, and hospital-acquired infections (HAIs), affecting 7-15% of inpatients. Aminoglycosides are vital for MDR tuberculosis (530,000 cases in 2022) and cystic fibrosis lung infections. Inhaled tobramycin and streptomycin’s inclusion in WHO’s Essential Medicines List boost demand. The global aminoglycosides market is estimated at USD 1.0-2.0 billion in 2025, with a CAGR of 3%-7% through 2030.

Regional Market Trends

  • North America: The U.S. leads with advanced ICU care for HAIs, while Canada focuses on cystic fibrosis treatments.
  • Europe: Germany, France, and the UK drive growth with robust infection control programs.
  • Asia Pacific: China and India see rising demand due to high MDR burden, with Japan emphasizing tuberculosis care.
  • Rest of the World: Africa prioritizes MDR-TB treatment, while Latin America addresses HAIs.

Application Analysis

  • Veterinary: Expected growth of 3.2%-7.2%, driven by livestock infections. Trends focus on regulated use.
  • Skin Infection: Projected growth of 3.0%-7.0%, linked to topical formulations. Advances emphasize combination therapies.
  • Respiratory Diseases: Anticipated growth of 3.5%-7.5%, tied to cystic fibrosis. Trends highlight inhaled therapies.
  • UTI & Pelvic Diseases: Expected growth of 3.3%-7.3%, suited for Gram-negative infections. Developments prioritize hospital use.
  • Other Diseases: Expected growth of 2.8%-6.8%, covering sepsis. Trends focus on combination regimens.

Type Analysis

  • Neomycin: Expected growth of 2.8%-6.8%, valued for topical use. Trends focus on OTC formulations.
  • Tobramycin: Projected growth of 3.5%-7.5%, favored for cystic fibrosis. Advances emphasize inhaled delivery.
  • Gentamicin: Anticipated growth of 3.2%-7.2%, critical for HAIs. Trends highlight combination therapies.
  • Amikacin: Expected growth of 3.4%-7.4%, suited for MDR infections. Developments prioritize IV formulations.
  • Paromomycin: Expected growth of 2.7%-6.7%, used for parasitic infections. Trends focus on niche indications.
  • Streptomycin: Expected growth of 3.3%-7.3%, vital for MDR-TB. Trends highlight WHO guidelines.
  • Kanamycin: Expected growth of 2.9%-6.9%, used in resistant infections. Developments prioritize generics.
  • Others: Expected growth of 2.6%-6.6%, covering novel analogs. Trends focus on resistance mitigation.

Key Market Players

  • Pfizer: Offers gentamicin for hospital infections.
  • Teva Pharmaceutical: Supplies affordable aminoglycosides.
  • AbbVie: Provides tobramycin for cystic fibrosis.
  • Merck: Develops amikacin formulations.
  • Cipla Limited: Focuses on generics for MDR-TB.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Low, due to complex manufacturing and regulatory barriers.
  • Threat of Substitutes: Moderate, with newer antibiotics competing, but aminoglycosides remain essential for MDR.
  • Bargaining Power of Buyers: High, as generics increase price competition.
  • Bargaining Power of Suppliers: Low, with multiple API providers.
  • Competitive Rivalry: High, with generic manufacturers competing on price.

Market Opportunities and Challenges

Opportunities:

  • Addressing MDR infections, causing 1.27 million deaths annually.
  • Managing HAIs, affecting 7-15% of inpatients.
  • Leveraging WHO guidelines for MDR-TB treatment.
  • Utilizing inhaled tobramycin for cystic fibrosis.
  • Supporting infection control in high-burden regions.
  • Meeting demand from rising MDR prevalence.

Challenges:

  • Toxicity risks like nephrotoxicity requiring monitoring.
  • Competition from newer antibiotics.
  • Regulatory delays for novel formulations.
  • Price erosion due to generics.
  • Limited access in low-income regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Aminoglycosides Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Aminoglycosides Market in North America (2020-2030)
8.1 Aminoglycosides Market Size
8.2 Aminoglycosides Market by End Use
8.3 Competition by Players/Suppliers
8.4 Aminoglycosides Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Aminoglycosides Market in South America (2020-2030)
9.1 Aminoglycosides Market Size
9.2 Aminoglycosides Market by End Use
9.3 Competition by Players/Suppliers
9.4 Aminoglycosides Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Aminoglycosides Market in Asia & Pacific (2020-2030)
10.1 Aminoglycosides Market Size
10.2 Aminoglycosides Market by End Use
10.3 Competition by Players/Suppliers
10.4 Aminoglycosides Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Aminoglycosides Market in Europe (2020-2030)
11.1 Aminoglycosides Market Size
11.2 Aminoglycosides Market by End Use
11.3 Competition by Players/Suppliers
11.4 Aminoglycosides Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Aminoglycosides Market in MEA (2020-2030)
12.1 Aminoglycosides Market Size
12.2 Aminoglycosides Market by End Use
12.3 Competition by Players/Suppliers
12.4 Aminoglycosides Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Aminoglycosides Market (2020-2025)
13.1 Aminoglycosides Market Size
13.2 Aminoglycosides Market by End Use
13.3 Competition by Players/Suppliers
13.4 Aminoglycosides Market Size by Type
Chapter 14 Global Aminoglycosides Market Forecast (2025-2030)
14.1 Aminoglycosides Market Size Forecast
14.2 Aminoglycosides Application Forecast
14.3 Competition by Players/Suppliers
14.4 Aminoglycosides Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Aminoglycosides Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.2 Teva Pharmaceutical
15.2.1 Company Profile
15.2.2 Main Business and Aminoglycosides Information
15.2.3 SWOT Analysis of Teva Pharmaceutical
15.2.4 Teva Pharmaceutical Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.3 AbbVie
15.3.1 Company Profile
15.3.2 Main Business and Aminoglycosides Information
15.3.3 SWOT Analysis of AbbVie
15.3.4 AbbVie Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.4 Merck
15.4.1 Company Profile
15.4.2 Main Business and Aminoglycosides Information
15.4.3 SWOT Analysis of Merck
15.4.4 Merck Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.5 Cipla Limited
15.5.1 Company Profile
15.5.2 Main Business and Aminoglycosides Information
15.5.3 SWOT Analysis of Cipla Limited
15.5.4 Cipla Limited Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.6 Viatris
15.6.1 Company Profile
15.6.2 Main Business and Aminoglycosides Information
15.6.3 SWOT Analysis of Viatris
15.6.4 Viatris Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.7 Sun Pharmaceutical
15.7.1 Company Profile
15.7.2 Main Business and Aminoglycosides Information
15.7.3 SWOT Analysis of Sun Pharmaceutical
15.7.4 Sun Pharmaceutical Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.8 Aurobindo Pharma
15.8.1 Company Profile
15.8.2 Main Business and Aminoglycosides Information
15.8.3 SWOT Analysis of Aurobindo Pharma
15.8.4 Aurobindo Pharma Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.9 Lupin Limited
15.9.1 Company Profile
15.9.2 Main Business and Aminoglycosides Information
15.9.3 SWOT Analysis of Lupin Limited
15.9.4 Lupin Limited Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
15.10 Fresenius Kabi
15.10.1 Company Profile
15.10.2 Main Business and Aminoglycosides Information
15.10.3 SWOT Analysis of Fresenius Kabi
15.10.4 Fresenius Kabi Aminoglycosides Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Aminoglycosides Report
Table Data Sources of Aminoglycosides Report
Table Major Assumptions of Aminoglycosides Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Aminoglycosides Picture
Table Aminoglycosides Classification
Table Aminoglycosides Applications
Table Drivers of Aminoglycosides Market
Table Restraints of Aminoglycosides Market
Table Opportunities of Aminoglycosides Market
Table Threats of Aminoglycosides Market
Table COVID-19 Impact For Aminoglycosides Market
Table Raw Materials Suppliers
Table Different Production Methods of Aminoglycosides
Table Cost Structure Analysis of Aminoglycosides
Table Key End Users
Table Latest News of Aminoglycosides Market
Table Merger and Acquisition
Table Planned/Future Project of Aminoglycosides Market
Table Policy of Aminoglycosides Market
Table 2020-2030 North America Aminoglycosides Market Size
Figure 2020-2030 North America Aminoglycosides Market Size and CAGR
Table 2020-2030 North America Aminoglycosides Market Size by Application
Table 2020-2025 North America Aminoglycosides Key Players Revenue
Table 2020-2025 North America Aminoglycosides Key Players Market Share
Table 2020-2030 North America Aminoglycosides Market Size by Type
Table 2020-2030 United States Aminoglycosides Market Size
Table 2020-2030 Canada Aminoglycosides Market Size
Table 2020-2030 Mexico Aminoglycosides Market Size
Table 2020-2030 South America Aminoglycosides Market Size
Figure 2020-2030 South America Aminoglycosides Market Size and CAGR
Table 2020-2030 South America Aminoglycosides Market Size by Application
Table 2020-2025 South America Aminoglycosides Key Players Revenue
Table 2020-2025 South America Aminoglycosides Key Players Market Share
Table 2020-2030 South America Aminoglycosides Market Size by Type
Table 2020-2030 Brazil Aminoglycosides Market Size
Table 2020-2030 Argentina Aminoglycosides Market Size
Table 2020-2030 Chile Aminoglycosides Market Size
Table 2020-2030 Peru Aminoglycosides Market Size
Table 2020-2030 Asia & Pacific Aminoglycosides Market Size
Figure 2020-2030 Asia & Pacific Aminoglycosides Market Size and CAGR
Table 2020-2030 Asia & Pacific Aminoglycosides Market Size by Application
Table 2020-2025 Asia & Pacific Aminoglycosides Key Players Revenue
Table 2020-2025 Asia & Pacific Aminoglycosides Key Players Market Share
Table 2020-2030 Asia & Pacific Aminoglycosides Market Size by Type
Table 2020-2030 China Aminoglycosides Market Size
Table 2020-2030 India Aminoglycosides Market Size
Table 2020-2030 Japan Aminoglycosides Market Size
Table 2020-2030 South Korea Aminoglycosides Market Size
Table 2020-2030 Southeast Asia Aminoglycosides Market Size
Table 2020-2030 Australia Aminoglycosides Market Size
Table 2020-2030 Europe Aminoglycosides Market Size
Figure 2020-2030 Europe Aminoglycosides Market Size and CAGR
Table 2020-2030 Europe Aminoglycosides Market Size by Application
Table 2020-2025 Europe Aminoglycosides Key Players Revenue
Table 2020-2025 Europe Aminoglycosides Key Players Market Share
Table 2020-2030 Europe Aminoglycosides Market Size by Type
Table 2020-2030 Germany Aminoglycosides Market Size
Table 2020-2030 France Aminoglycosides Market Size
Table 2020-2030 United Kingdom Aminoglycosides Market Size
Table 2020-2030 Italy Aminoglycosides Market Size
Table 2020-2030 Spain Aminoglycosides Market Size
Table 2020-2030 Belgium Aminoglycosides Market Size
Table 2020-2030 Netherlands Aminoglycosides Market Size
Table 2020-2030 Austria Aminoglycosides Market Size
Table 2020-2030 Poland Aminoglycosides Market Size
Table 2020-2030 Russia Aminoglycosides Market Size
Table 2020-2030 MEA Aminoglycosides Market Size
Figure 2020-2030 MEA Aminoglycosides Market Size and CAGR
Table 2020-2030 MEA Aminoglycosides Market Size by Application
Table 2020-2025 MEA Aminoglycosides Key Players Revenue
Table 2020-2025 MEA Aminoglycosides Key Players Market Share
Table 2020-2030 MEA Aminoglycosides Market Size by Type
Table 2020-2030 Egypt Aminoglycosides Market Size
Table 2020-2030 Israel Aminoglycosides Market Size
Table 2020-2030 South Africa Aminoglycosides Market Size
Table 2020-2030 Gulf Cooperation Council Countries Aminoglycosides Market Size
Table 2020-2030 Turkey Aminoglycosides Market Size
Table 2020-2025 Global Aminoglycosides Market Size by Region
Table 2020-2025 Global Aminoglycosides Market Size Share by Region
Table 2020-2025 Global Aminoglycosides Market Size by Application
Table 2020-2025 Global Aminoglycosides Market Share by Application
Table 2020-2025 Global Aminoglycosides Key Vendors Revenue
Figure 2020-2025 Global Aminoglycosides Market Size and Growth Rate
Table 2020-2025 Global Aminoglycosides Key Vendors Market Share
Table 2020-2025 Global Aminoglycosides Market Size by Type
Table 2020-2025 Global Aminoglycosides Market Share by Type
Table 2025-2030 Global Aminoglycosides Market Size by Region
Table 2025-2030 Global Aminoglycosides Market Size Share by Region
Table 2025-2030 Global Aminoglycosides Market Size by Application
Table 2025-2030 Global Aminoglycosides Market Share by Application
Table 2025-2030 Global Aminoglycosides Key Vendors Revenue
Figure 2025-2030 Global Aminoglycosides Market Size and Growth Rate
Table 2025-2030 Global Aminoglycosides Key Vendors Market Share
Table 2025-2030 Global Aminoglycosides Market Size by Type
Table 2025-2030 Aminoglycosides Global Market Share by Type

Companies Mentioned

  • Pfizer
  • Teva Pharmaceutical
  • AbbVie
  • Merck
  • Cipla Limited
  • Viatris
  • Sun Pharmaceutical
  • Aurobindo Pharma
  • Lupin Limited
  • Fresenius Kabi

Related Topics

Related Reports

Aminoglycosides - Global Strategic Business Report - Product Image

Aminoglycosides - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030 - Product Image

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030

  • Report
  • 105 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Image

Aminoglycosides Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Aminoglycosides Market - Global Forecast 2025-2032 - Product Image

Aminoglycosides Market - Global Forecast 2025-2032

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.